| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-17-0652 |
| P698 | PubMed publication ID | 28674118 |
| P50 | author | Franck Bourdeaut | Q66360615 |
| Garrett M Brodeur | Q85737948 | ||
| William David Foulkes | Q37829195 | ||
| P2093 | author name string | Akira Nakagawara | |
| Alison H Skalet | |||
| Lisa J States | |||
| Andreu Parareda | |||
| Junne Kamihara | |||
| Michael F Walsh | |||
| Lisa R Diller | |||
| Jan J Molenaar | |||
| Kami Wolfe Schneider | |||
| Sarah R Scollon | |||
| Yaël P Mossé | |||
| P2860 | cites work | Relative frequency and morphology of cancers in carriers of germline TP53 mutations | Q57266809 |
| Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group | Q57734267 | ||
| Genetic Predisposition to Familial Neuroblastoma: Identification of Two Novel Genomic Regions at 2p and 12p | Q58328226 | ||
| PHOX2B mutations and genetic predisposition to neuroblastoma | Q58328232 | ||
| Retinoblastoma | Q58347703 | ||
| History and current status of neuroblastoma screening in Japan | Q69758404 | ||
| Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections | Q70053694 | ||
| Noonan Syndrome and Neuroblastoma | Q71794877 | ||
| A recognizable pattern of the midface of retinoblastoma patients with interstitial deletion of 13q | Q71826950 | ||
| Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma | Q73249413 | ||
| Chemoreduction for retinoblastoma may prevent trilateral retinoblastoma | Q73330215 | ||
| Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma | Q73381855 | ||
| Familial retinoblastoma: where and when? | Q74827866 | ||
| Genotype-phenotype correlations in hereditary familial retinoblastoma | Q79346049 | ||
| A case of rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and neural crest tumor: ROHHADNET syndrome | Q85552239 | ||
| Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups | Q87911260 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| Identification of ALK as a major familial neuroblastoma predisposition gene | Q24655923 | ||
| Activating mutations in ALK provide a therapeutic target in neuroblastoma | Q27851452 | ||
| Dysmorphic phenotype and neurological impairment in 22 retinoblastoma patients with constitutional cytogenetic 13q deletion | Q28142341 | ||
| Retinoblastoma associated with chromosomal 13q14 deletion mosaicism | Q28206254 | ||
| A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma | Q29618817 | ||
| The E2F transcription factor is a cellular target for the RB protein | Q29620422 | ||
| Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr. | Q30491849 | ||
| Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. | Q31120259 | ||
| Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study | Q33555866 | ||
| Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma | Q33773317 | ||
| Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma | Q33909753 | ||
| Enhanced sensitivity for detection of low-level germline mosaic RB1 mutations in sporadic retinoblastoma cases using deep semiconductor sequencing | Q33956073 | ||
| Screening of infants and mortality due to neuroblastoma | Q34122052 | ||
| Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy | Q34260518 | ||
| Retinoblastoma: revisiting the model prototype of inherited cancer | Q34334590 | ||
| Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up | Q34407554 | ||
| Trilateral retinoblastoma: a systematic review and meta-analysis. | Q34433758 | ||
| Neuroblastoma Screening at One Year of Age | Q56637925 | ||
| Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma | Q57199414 | ||
| The Incidence of Trilateral Retinoblastoma: A Systematic Review and Meta-Analysis | Q34494341 | ||
| Lifetime risks of common cancers among retinoblastoma survivors | Q34546040 | ||
| Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences | Q34550273 | ||
| Diagnosis and management of retinoblastoma | Q34551012 | ||
| Patterns of risk of hereditary retinoblastoma and applications to genetic counselling | Q34563696 | ||
| The contribution of associated congenital anomalies in understanding Hirschsprung's disease | Q34565449 | ||
| Malignant diseases in Noonan syndrome and related disorders | Q34615128 | ||
| National Retinoblastoma Strategy Canadian Guidelines for Care: Stratégie thérapeutique du rétinoblastome guide clinique canadien | Q34617828 | ||
| Mortality from second tumors among long-term survivors of retinoblastoma | Q34729393 | ||
| Ondine-Hirschsprung syndrome (Haddad syndrome). Further delineation in two cases and review of the literature. | Q34730563 | ||
| Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk | Q34743299 | ||
| Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk | Q34746790 | ||
| Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood | Q34796391 | ||
| Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. | Q34907470 | ||
| Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma | Q35105514 | ||
| Familial neuroblastoma: a complex heritable disease. | Q35184930 | ||
| Congenital central hypoventilation syndrome and Hirschsprung's disease | Q35259161 | ||
| Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes | Q35475470 | ||
| Mutation and cancer: neuroblastoma and pheochromocytoma | Q35569133 | ||
| Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study | Q35603507 | ||
| ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome | Q35768388 | ||
| Occurrence of Neuroblastoma among TP53 p.R337H Carriers | Q35801794 | ||
| Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma. | Q35830949 | ||
| Cognitive and behavioral outcomes after early exposure to anesthesia and surgery | Q35838714 | ||
| Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. | Q35881994 | ||
| Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours | Q35993050 | ||
| Tumor predisposition in Costello syndrome | Q36190676 | ||
| Germline Mutations in Predisposition Genes in Pediatric Cancer | Q36524309 | ||
| Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth | Q36592140 | ||
| In utero detection of retinoblastoma with fetal magnetic resonance and ultrasound: initial experience | Q36842678 | ||
| Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951-2004. | Q36959083 | ||
| Genetic testing and tumor surveillance for children with cancer predisposition syndromes | Q37057712 | ||
| Early exposure to anesthesia and learning disabilities in a population-based birth cohort | Q37312210 | ||
| Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. | Q37467387 | ||
| Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. | Q37646416 | ||
| Rare variants in TP53 and susceptibility to neuroblastoma. | Q37696703 | ||
| Review of 676 second primary tumors in patients with retinoblastoma: association between age at onset and tumor type | Q37772023 | ||
| Managing fetuses at high risk of retinoblastoma: lesion detection on screening MRI. | Q38256933 | ||
| Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up | Q38452875 | ||
| RB1 gene inactivation by chromothripsis in human retinoblastoma | Q38457744 | ||
| Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol | Q38884321 | ||
| Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies | Q39180520 | ||
| Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center | Q39448081 | ||
| RB1 mutations and second primary malignancies after hereditary retinoblastoma | Q39671293 | ||
| Synchronous neuroblastoma and von Recklinghausen's disease: a review of the literature | Q39845522 | ||
| Oncogenic mutations of ALK kinase in neuroblastoma | Q39928776 | ||
| Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma | Q39928780 | ||
| Pediatric second primary malignancies after retinoblastoma treatment | Q40943598 | ||
| Identification of GALNT14 as a novel neuroblastoma predisposition gene | Q41450595 | ||
| Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors | Q41783629 | ||
| Germline PHOX2B mutation in hereditary neuroblastoma | Q42586619 | ||
| Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands | Q42841909 | ||
| At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98. | Q43093484 | ||
| Delay in diagnosis of retinoblastoma: risk factors and treatment outcome | Q43094150 | ||
| Canadian guidelines for retinoblastoma care | Q43211178 | ||
| Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study | Q43759412 | ||
| Hereditary retinoblastoma transmitted by maternal germline mosaicism | Q43815404 | ||
| Outcomes of integrating genetics in management of patients with retinoblastoma | Q43955343 | ||
| Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group | Q44238288 | ||
| RB1 mutation spectrum in a comprehensive nationwide cohort of retinoblastoma patients | Q44283852 | ||
| Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival | Q44678897 | ||
| Prenatal versus Postnatal Screening for Familial Retinoblastoma | Q46186950 | ||
| Noonan syndrome associated with neuroblastoma: a case report. | Q46514658 | ||
| Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era. | Q46646150 | ||
| Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction | Q46774451 | ||
| Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations | Q47936860 | ||
| Retinoblastoma and intracranial malignancy | Q48294739 | ||
| Human retinoblastoma susceptibility gene: cloning, identification, and sequence | Q48348004 | ||
| Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype | Q48493763 | ||
| Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era. | Q48870597 | ||
| Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. | Q52548317 | ||
| The international incidence of childhood cancer. | Q53413384 | ||
| PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations. | Q53623196 | ||
| Cancer: A ringleader identified. | Q54795249 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | retinoblastoma | Q500695 |
| neuroblastoma | Q938205 | ||
| P304 | page(s) | e98-e106 | |
| P577 | publication date | 2017-07-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Retinoblastoma and Neuroblastoma Predisposition and Surveillance | |
| P478 | volume | 23 |
| Q64043699 | Application of genome analysis strategies in the clinical testing for pediatric diseases |
| Q97645457 | Clinical Features of Children with Retinoblastoma and Neuroblastoma |
| Q89623078 | Diagnosis and Management of Beckwith-Wiedemann Syndrome |
| Q90423733 | Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2 |
| Q53824005 | Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis. |
| Q55378789 | Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma. |
| Q57166441 | Genetic Predisposition to Neuroblastoma |
| Q52339753 | Genetic susceptibility to neuroblastoma: current knowledge and future directions. |
| Q90298760 | HOXB5 promotes retinoblastoma cell migration and invasion via ERK1/2 pathway-mediated MMPs production |
| Q47863034 | Incidental neuroblastoma with bilateral retinoblastoma: what are the chances? |
| Q90085168 | Multifocal primary neuroblastoma tumor heterogeneity in siblings with co-occurring PHOX2B and NF1 genetic aberrations |
| Q91964988 | Next-Generation Technologies and Strategies for the Management of Retinoblastoma |
| Q92654730 | PET/CT and PET/MRI in ophthalmic oncology (Review) |
| Q98386959 | Pediatric Somatic Tumor Sequencing Identifies Underlying Cancer Predisposition |
| Q57789224 | Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes |
| Q96348276 | Regulating tumor suppressor genes: post-translational modifications |
| Q92095846 | Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells |
| Q48288706 | Retinoblastoma, the visible CNS tumor: A review |
| Q93009410 | Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma |
| Q94540233 | Variability in retinoblastoma genome stability is driven by age and not heritability |
Search more.